Literature DB >> 33178866

Relative Expression of SOX2 and OCT4 in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia.

Narges Ghazi1, Narges Aali2, Vahid-Reza Shahrokhi2, Farnaz Mohajertehran1,2, Nasrollah Saghravanian2.   

Abstract

BACKGROUND: Over 90% of oral cancers including oral squamous cell carcinoma (OSCC), originate from the oral cavity epithelium. Early detection for this lesion is as important. Evaluating cancer stem cell markers can improve the accuracy of early diagnosis, and be used as an OSCC prognostic indicator. We aimed to evaluate SOX2 and OCT4 gene expression among different grades of OSCC and oral epithelial dysplasia (OED) lesions.
METHODS: Sixty samples that contains 45 OSCC and 15 OED samples were retrieved from the pathology department archives at the dental school of Mashhad. Demographic and pathological patient data including the tumor stage and tumor grade were assessed. Finally, SOX2 and OCT4 expression was examined using qRT-PCR.
RESULTS: There was a significant difference in SOX2 and OCT4 expression between OSCC and OED samples (p< 0.001). The mean expression of SOX2 and OCT4 in OSCC samples were significantly higher than in the OED group (p< 0.001). The mean expression of SOX2 and OCT4 was higher in grade II and grade III OSCC compared to grade I. There was no significant relationship between the gene expression of SOX2 or OCT4 to the demographic, site and stage of tumors. The correlation between SOX2 and OCT4 expression (p= 0.001) was significant in grade III OSCC specimens compared to other grades (p= 0.005, r= 0.68).
CONCLUSION: The increased expression of SOX2 and OCT4 in higher grades and the significant correlation of these genes with each other among OSCC specimens could suggest the role of SOX2 or OCT4 in oral mucosal carcinogenesis.

Entities:  

Keywords:  OCT4; Oral Epithelial Dysplasia (OED); Oral Squamous Cell Carcinoma (OSCC); SOX2

Year:  2020        PMID: 33178866      PMCID: PMC7603259          DOI: 10.29252/rbmb.9.2.171

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  32 in total

1.  Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.

Authors:  Ting-Ying Fu; I-Chien Hsieh; Jiin-Tsuey Cheng; Meng-Han Tsai; Yu-Yi Hou; Jang-Hwa Lee; Huei-Han Liou; Sheng-Feng Huang; Hung-Chih Chen; Leing-Ming Yen; Hui-Hwa Tseng; Luo-Ping Ger
Journal:  J Oral Pathol Med       Date:  2015-07-25       Impact factor: 4.253

2.  SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.

Authors:  Rocío González-Márquez; José Luis Llorente; Juan P Rodrigo; Juana M García-Pedrero; César Álvarez-Marcos; Carlos Suárez; Mario A Hermsen
Journal:  Hum Pathol       Date:  2013-12-21       Impact factor: 3.466

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 4.  Clonogenic cells in acute myeloblastic leukemia.

Authors:  J D Griffin; B Löwenberg
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

5.  SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.

Authors:  Thomas Hussenet; Stanislas du Manoir
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

6.  Trends in the epidemiology of oral squamous cell carcinoma in Western UP: an institutional study.

Authors:  Preeti Sharma; Susmita Saxena; Pooja Aggarwal
Journal:  Indian J Dent Res       Date:  2010 Jul-Sep

7.  Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Nooshin Mohtasham; Hossein Ayatollahi; Nasrollah Saghravanian; Reza Zare; Mohammad-Taghi Shakeri; Amirhossein Sahebkar; Farnaz Mohajertehran
Journal:  Anticancer Agents Med Chem       Date:  2019       Impact factor: 2.505

8.  Survival, metastasis and recurrence of oral cancer in relation to pathological features.

Authors:  J A Woolgar; J Scott; E D Vaughan; J S Brown; C R West; S Rogers
Journal:  Ann R Coll Surg Engl       Date:  1995-09       Impact factor: 1.891

9.  SOX2 Expression Is an Independent Predictor of Oral Cancer Progression.

Authors:  Juan C de Vicente; Paula Donate-Pérez Del Molino; Juan P Rodrigo; Eva Allonca; Francisco Hermida-Prado; Rocío Granda-Díaz; Tania Rodríguez Santamarta; Juana M García-Pedrero
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

10.  Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.

Authors:  Fereshteh Baghai Naini; Pouyan Aminishakib; Alireza Abdollahi; Mahshid Hodjat; Hadiseh Mohammadpour; Neda Kardouni Khoozestani
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01
View more
  4 in total

1.  Pluripotency Stemness and Cancer: More Questions than Answers.

Authors:  Jiří Hatina; Michaela Kripnerová; Zbyněk Houdek; Martin Pešta; Filip Tichánek
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Melatonin Induced Schwann Cell Proliferation and Dedifferentiation Through NF-ĸB, FAK-Dependent but Src-Independent Pathways.

Authors:  Navishaa Govindasamy; Kian Chung Chok; Pei Ying Ng; Rhun Yian Koh; Soi Moi Chye
Journal:  Rep Biochem Mol Biol       Date:  2022-04

3.  Immunohistochemical and molecular profiling of CD 117, Oct-4, and Sox-2 in canine cutaneous mast cell tumor of the crossbred dogs in Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.

Authors:  Sirilak Meesuwan; Dettachai Ketpun; Prapruddee Piyaviriyakul; Kasem Rattanapinyopituk; Pattharakrit Theewasutrakul; Achariya Sailasuta
Journal:  Vet World       Date:  2021-10-15

4.  Downregulation of Stemness Genes and Induction of Necrosis in Rat LA7 Cancer Stem Cells Induced Tumors Treated with Starved Fibroblasts Culture Supernatant.

Authors:  Roghayeh Pourbagher; Hossein Ghorbani; Haleh Akhavan-Niaki; Seyed Gholam Ali Jorsaraei; Sadegh Fattahi; Sahar Ghooran; Zeinab Abedian; Masoumeh Ghasemi; Fatemeh Saeedi; Negar Jafari; Behnam Kalali; Amrollah Mostafazadeh
Journal:  Rep Biochem Mol Biol       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.